Related Experiment Video
Updated: Jul 3, 2026
06:15
Zebra II as A Novel System to Record Electrophysiological Signals in Zebrafish
Published on: August 16, 2024
Amiodarone hepatotoxicity
Mohamed Babatin1, Samuel S Lee, P Timothy Pollak
1Department of Medicine, University of Calgary, Calgary, Alberta, Canada.
Current Vascular Pharmacology
|August 5, 2008
Summary
Amiodarone can cause liver damage (hepatotoxicity) at any time during treatment or even after stopping the drug. Monitoring liver function is crucial for patients receiving amiodarone therapy.
Area of Science:
- Pharmacology
- Hepatology
- Clinical Medicine
Background:
- Amiodarone is a widely used antiarrhythmic drug.
- Hepatotoxicity is a known potential adverse effect of amiodarone therapy.
- Current understanding of amiodarone-induced liver injury and optimal monitoring strategies is limited.
Purpose of the Study:
- To review the existing literature on amiodarone-associated liver effects.
- To examine the incidence, pathogenesis, and mechanisms of amiodarone hepatotoxicity.
- To provide clinical recommendations for monitoring liver function in patients on amiodarone.
Main Methods:
- Literature review of studies on amiodarone and liver effects.
- Emphasis on clinical data and expert consensus.
- Analysis of incidence, risk factors, and monitoring guidelines.
Main Results:
- Amiodarone-induced hepatotoxicity can occur at any point during therapy, including early intravenous use and after discontinuation.
- Most cases are asymptomatic and detected incidentally via liver biochemistry tests.
- Severe symptomatic liver injury or failure is rare.
Conclusions:
- Hepatotoxicity is a significant concern with amiodarone, requiring careful consideration.
- Optimal monitoring protocols for amiodarone-treated patients are not well-established.
- Further prospective studies are needed to clarify incidence and guide monitoring practices.
Related Concept Videos
01:12Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...
01:22Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
01:24Drug Toxicity: Risk factors
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
01:00Drug Toxicity: Overview
Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...
01:24Drug Toxicity: Dose-Dependent Reactions
Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...